American Health Packaging is recalling 4,508 blister packs of Nitrofurantoin Capsules USP (100 mg), a prescription antibiotic used to treat urinary tract infections. This recall was initiated because the medication may contain trace amounts of unrelated active ingredients, specifically Benazepril, Haloperidol, and Perphenazine, due to a manufacturing issue at the original production facility. These affected 100-count unit dose blisters were distributed nationwide across the United States.
The presence of unintended active pharmaceutical ingredients like Haloperidol (an antipsychotic) or Benazepril (a blood pressure medication) poses a risk of adverse drug reactions or unintended side effects if consumed. No specific injuries or incidents were reported in this data, but the contamination was identified during a manufacturing investigation.
Healthcare consultation and pharmacy return
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.